Etanercept as an adjuvant to interferon and ribavirin in treatment-naive patients with chronic hepatitis C virus infection: a phase 2 randomized, double-blind, placebo-controlled study
Year: 2004
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: Journal of Hepatology
Institution: Mayo Clinic
Language: English
Topic: Hepatitis C virus research
Subfield: Hepatology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Funders: Amgen, Bayer Corporation
OpenAlex ID: W2170889678
